References
- Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.
- de Kraker ME, Davey PG, Grundmann H; BURDEN Study Group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8:e1001104.
- European Centre for Disease Prevention and Control. The bacterial challenge: time to react. A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents. Stockholm: European Centre for Disease Prevention and Control, 2009. Available at http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. accessed 14 January 2014.
- Leung E, Weil DE, Raviglione M, Nakatani H; World Health Organization World Health Day Antimicrobial Resistance Technical Working Group. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ. 2011;89:390–2.
- European Commission. The European Commission's 2011 action plan against the rising threats from antimicrobial resistance. 2011. Available at http://ec.europa.eu/dgs/health_consumer/docs/communication_amr_2011_748_en.pdf. accessed 14 January 2014.
- Infectious Diseases Society of America. Promoting Antimicrobial Stewardship in Human Medicine. Available at http://www.idsociety.org/stewardship_policy/#sthash.xKOIwFmV.dpuf. accessed 14 January 2014.
- Swedish Institute for Communicable Disease Control, National Veterinary Institute. A Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine (SWEDRES) and Swedish Veterinary Antimicrobial Resistance Monitoring (SVARM). 2012. Available at http://www.folkhalsomyndigheten.se/publicerat-material/publikationer/SWEDRESSVARM-2012/. accessed 14 January 2014.
- Strama. Swedish point prevalence studies on antibiotic use in hospitals. 2003-2010. Available at http://folkhalsomyndigheten.se/amnesomraden/statistik-och-undersokningar/antibiotikastatistik/sverige/slutenvard/. accessed 17 March 2014.
- Hanberger H, Odenholt I, Giske CG, Kahlmeter G. [Time to abandon “the house wine”. Stop for uncritical empiric use of cefuroxime]. Lakartidningen. 2009;106:291–2.
- Dornbusch K, Bengtsson S, Brorson JE, Fritz H, Henning C, Kronvall G, et al. Susceptibility to beta-lactam antibiotics and gentamycin of gram-negative bacilli isolated from hospitalized patients: a Swedish multicenter study. Scand J Inf Dis. 1988;20:641–7.
- Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, et al. Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care. 2010;14:R126.
- Swedish Society of Infectious Diseases, Sepsis Working Group. Guidelines for severe sepsis and septic shock. 2012. Available at http://www.infektion.net/v%C3%A5rdprogram-f%C3%B6r-sv%C3%A5r-sepsisseptisk-chock. accessed 14 January 2014.
- EUCAST. Piperacillin-tazobactam, Rationale for the EUCAST clinical breakpoints, version 1.0. 2010. Available at http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Piperacillin-tazobactam_rationale_ Nov2010_v_1.0.pdf. accessed 20 March 2014.
- Ostholm-Balkhed A, Tarnberg M, Nilsson M, Nilsson LE, Hanberger H, Hallgren A, et al. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother. 2013;68:2144–53.
- Tangden T, Eriksson BM, Melhus A, Svennblad B, Cars O. Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2011;66:1161–7.
- Ashiru-Oredope D, Sharland M, Charani E, McNulty C, Cooke J; ARHAI Antimicrobial Stewardship Group. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother. 2012;67 (Suppl 1):i51–63.
- Livermore DM, Hope R, Reynolds R, Blackburn R, Johnson AP, Woodford N. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother. 2013;68:2667–74.
- European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance interactive database (EARS-Net). 2013. Available at http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/table_reports.aspx. accessed 16 March 2014.
- Otete EH, Ahankari AS, Jones H, Bolton KJ, Jordan CW, Boswell TC, et al. Parameters for the mathematical modelling of Clostridium difficile acquisition and transmission: a systematic review. PLoS One. 2013;8:e84224.
- Toepfer M, Magnusson C, Noren T, Hansen I, Iveroth P, Offenbartl K. [Insidious and widespread outbreak of Clostridium difficile. Changed cleaning procedures and frequent evaluations cut infection rates in half]. Lakartidningen. 2014;111:24–7.
- Linner A, Sunden-Cullberg J, Johansson L, Hjelmqvist H, Norrby-Teglund A, Treutiger CJ. Short- and long-term mortality in severe sepsis/septic shock in a setting with low antibiotic resistance: a prospective observational study in a Swedish university hospital. Front Public Health. 2013;1:51.
- Ammerlaan HS, Harbarth S, Buiting AG, Crook DW, Fitzpatrick F, Hanberger H, et al. Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis. 2013;56:798–805.
- Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis. 1997;24:1068–78.